Unknown

Dataset Information

0

Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid.


ABSTRACT: Angiotensin-(1-7) [Ang-(1-7)], a heptapeptide hormone of the renin-angiotensin-aldosterone system, is a promising candidate as a treatment for cancer that reflects its anti-proliferative and anti-angiogenic properties. However, the peptide's therapeutic potential is limited by the short half-life and low bioavailability resulting from rapid enzymatic metabolism by peptidases including angiotensin-converting enzyme (ACE) and dipeptidyl peptidase 3 (DPP 3). We report the facile assembly of three novel Ang-(1-7) analogues by solid-phase peptide synthesis which incorporates the cyclic non-natural δ-amino acid ACCA. The analogues containing the ACCA substitution at the site of ACE cleavage exhibit complete resistance to human ACE, while substitution at the DDP 3 cleavage site provided stability against DPP 3 hydrolysis. Furthermore, the analogues retain the anti-proliferative properties of Ang-(1-7) against the 4T1 and HT-1080 cancer cell lines. These results suggest that ACCA-substituted Ang-(1-7) analogues which show resistance against proteolytic degradation by peptidases known to hydrolyze the native heptapeptide may be novel therapeutics in the treatment of cancer.

SUBMITTER: Wester A 

PROVIDER: S-EPMC9239115 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6402262 | biostudies-literature
| S-EPMC3901690 | biostudies-literature
| S-EPMC1130874 | biostudies-other
| S-EPMC8613857 | biostudies-literature
| S-EPMC5529024 | biostudies-literature
| S-EPMC7341133 | biostudies-literature
| S-EPMC307629 | biostudies-literature
| S-EPMC9366462 | biostudies-literature
| S-EPMC8009597 | biostudies-literature
| S-EPMC2588515 | biostudies-literature